MedPath

RETISOL-A

RETISOL-A

Discontinued
DIN Number

02008718

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02008718
AIG Number0324478004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D10AD51 TRETINOIN, COMBINATIONS
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

AVOBENZONEActive
Strength: 2 %
Monograph: AVOBENZONE
OCTINOXATEActive
Strength: 7.5 %
Monograph: OCTINOXATE
TRETINOINActive
Strength: 0.05 %
Monograph: TRETINOIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.